Hr-positive Breast Cancer
📧 Sign up to get email alerts when something new happens for Hr-positive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial of GTAEXS617 in adults with advanced solid tumors is currently recruiting. The study encompasses head and neck sq…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases [Phase 2]
A Phase 2 clinical trial evaluating brain radiotherapy combined with dalpiciclib and endocrine therapy for HR-positive/HER2-negative advance…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer [Phase 3]
Phase 3 study evaluating RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant for locally advanced or metastatic PIK3CA-mutant HR+/HER2- bre…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer [Phase 2]
This document reports that the Phase 2 trial of QL1706 for neoadjuvant treatment of HR+/HER2- breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Real-world clinical trial update on sacituzumab govitecan as monotherapy or in combination for recurrent or metastatic HER2-negative breast …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer [Phase 2]
This clinical trial update indicates a Phase 2 neoadjuvant study of Darsilide combined with an aromatase inhibitor, trastuzumab, and Patuzum…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC. [Phase 2]
A Phase 2 study evaluating radiotherapy followed by chemotherapy in combination with toripalimab for locally advanced HR-positive, HER2-nega…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating a PARP inhibitor with a CDK4/6 inhibitor and endocrine therapy for HR+/HER2-negative metastatic breast can…
-
CLINICAL_TRIALS research · 2018-06-18Clinical Trial Update: A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer [Phase 2]
Phase 2 biomarker study evaluating the combination of palbociclib and fulvestrant in second- or third-line HR+/HER2-negative advanced breast…